Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q2 2023 Earnings

8MayConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

-0.27

-0.24

-0.2

-0.17

Details

Expected EPS

-0.21

Actual EPS

-0.27

Surprise EPS

-0.06

Surprise Percent

+28.57%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.27 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.